Aquestive Therapeutics, Inc. (AQST) Total liabilities 2017–2025
Aquestive Therapeutics, Inc. (AQST) total liabilities at each fiscal year-end, per SEC filings.
$194.1MFY2025 · since FY2017: $69.6M → $194.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $194.1M | +20.1% |
| FY2024 | $161.6M | -1.4% |
| FY2023 | $163.9M | -6.7% |
| FY2022 | $175.6M | +21.9% |
| FY2021 | $144.1M | +29.4% |
| FY2020 | $111.4M | +31.7% |
| FY2019 | $84.6M | +10.2% |
| FY2018 | $76.8M | +10.3% |
| FY2017 | $69.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice